The Primary
Care Companionfor CNS Disorders

Bipolar Disorder

Letter to the Editor October 15, 2004

Management of Bipolar Disorder in Primary Care Versus Psychiatric Settings

J. Sloan Manning, MD

Prim Care Companion J Clin Psychiatry 2004;6(5):222-223

Article Abstract

Letter to the Editor

Download Free PDF

This PDF is free for all visitors!

Save

Cite

INFORMATION FROM INDUSTRY

AUVELITY is an FDA-approved treatment for adults with MDD. Auvelity, is a rapid-acting antidepressant with a multimodal mechanism, targeting both glutamatergic and monoaminergic pathways. Learn more about how AUVELITY is thought to work and side effects. Please see Important Safety Information within this document and the full Prescribing Information.

Vol 27 • 2025 • Number 1

Read the Current Issue

Case Report

Thyrotoxic Psychosis in Graves’ Disease

Rounds in the General Hospital

Psychosis-Related PTSD

Case Report

Factitious Disorder in the Context of Abuse in an Adolescent

Rounds in the General Hospital

Wishing That Your Patient Would Die: Reasons and Reactions

Case Report

Frontal Lobe Syndrome Unveils an Unexpected Diagnosis

Case Report

Low-Dose Clozapine in Schizophrenia With Aggression

View current Issue

Letter to the Editor

Antidepressant Effects of Combined Mood Stabilizers May Account for High Placebo Response Rates

June 22, 2021

Dr Terao comments on the methodology of a recent study evaluating citalopram for bipolar depression.

Takeshi Terao

Letter to the Editor

Antidepressants Added Nothing to Mood Stabilizers Alone: Reply to Terao

June 22, 2021

Dr Ghaemi responds to Dr Terao’s letter regarding a study of citalopram for bipolar depression.

S. Nassir Ghaemi

Letter to the Editor

Adjunctive Mood Stabilizers Are Not the Same As a Placebo-Only Arm in Bipolar Depression Trials: Reply to Terao

June 22, 2021

Dr Goldberg responds to Dr Terao’s letter regarding a study of citalopram for bipolar depression.

Joseph F. Goldberg

Management of Bipolar Disorder in Primary Care Versus Psychiatric Settings

Read the Current Issue

Thyrotoxic Psychosis in Graves’ Disease

Psychosis-Related PTSD

Factitious Disorder in the Context of Abuse in an Adolescent

Wishing That Your Patient Would Die: Reasons and Reactions

Frontal Lobe Syndrome Unveils an Unexpected Diagnosis

Low-Dose Clozapine in Schizophrenia With Aggression

ELSEWHERE:

FOLLOW US:

Management of Bipolar Disorder in Primary Care Versus Psychiatric Settings

Read the Current Issue

Thyrotoxic Psychosis in Graves’ Disease

Psychosis-Related PTSD

Factitious Disorder in the Context of Abuse in an Adolescent

Wishing That Your Patient Would Die: Reasons and Reactions

Frontal Lobe Syndrome Unveils an Unexpected Diagnosis

Low-Dose Clozapine in Schizophrenia With Aggression

Related Articles

Antidepressant Effects of Combined Mood Stabilizers May Account for High Placebo Response Rates

Antidepressants Added Nothing to Mood Stabilizers Alone: Reply to Terao

Adjunctive Mood Stabilizers Are Not the Same As a Placebo-Only Arm in Bipolar Depression Trials: Reply to Terao

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles